Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 614,528
  • Shares Outstanding, K 14,298
  • Annual Sales, $ 126,080 K
  • Annual Income, $ -11,540 K
  • EBIT $ -9 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.30
  • Price/Sales 5.07
  • Price/Cash Flow 138.92
  • Price/Book 5.52
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.24
  • Most Recent Earnings $0.06 on 08/08/25
  • Next Earnings Date 11/26/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -0.19
  • Number of Estimates 2
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.13
  • Growth Rate Est. (year over year) -46.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.87 +66.14%
on 11/05/25
43.00 -0.06%
on 11/18/25
+14.99 (+53.55%)
since 10/17/25
3-Month
25.87 +66.14%
on 11/05/25
43.00 -0.06%
on 11/18/25
+6.09 (+16.51%)
since 08/18/25
52-Week
25.87 +66.14%
on 11/05/25
43.00 -0.06%
on 11/18/25
+3.73 (+9.50%)
since 11/18/24

Most Recent Stories

More News
Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today

Surmodics, Inc. (Nasdaq: SRDX) (“Surmodics” or the “Company”), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that it expects...

SRDX : 42.98 (+0.35%)
Stocks Settle Mostly Higher on Government Reopening Optimism

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.31%. December E-mini...

AMAT : 260.78 (+0.21%)
AVGO : 350.22 (+0.26%)
MRK : 106.45 (+1.34%)
RGTI : 24.51 (-2.39%)
$IUXX : 25,656.15 (+0.27%)
AMGN : 333.96 (+0.75%)
PFE : 25.03 (+0.60%)
ELV : 343.30 (+0.02%)
ASML : 1,065.52 (+0.35%)
ZNH26 : 112-175 (+0.03%)
CRWV : 78.87 (-1.73%)
VRTS : 166.56 (+0.62%)
Dow and S&P Rise as Nasdaq Faces Selling Pressure

The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.19%. US stock indexes are mixed...

AMAT : 260.78 (+0.21%)
AVGO : 350.22 (+0.26%)
RKLB : 77.18 (unch)
RGTI : 24.51 (-2.39%)
$IUXX : 25,656.15 (+0.27%)
ASML : 1,065.52 (+0.35%)
ZNH26 : 112-175 (+0.03%)
CRWV : 78.87 (-1.73%)
PSKY : 13.74 (+1.55%)
SRDX : 42.98 (+0.35%)
LRCX : 177.33 (+1.24%)
AMD : 215.04 (+0.07%)
Stocks Pressured by AI Jitters and Signs of US Labor Market Weakness

The S&P 500 Index ($SPX ) (SPY ) today is down -0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.42%. December E-mini S&P futures...

AMAT : 260.78 (+0.21%)
RKLB : 77.18 (unch)
RGTI : 24.51 (-2.39%)
$IUXX : 25,656.15 (+0.27%)
ZNH26 : 112-175 (+0.03%)
CRWV : 78.87 (-1.73%)
ESH26 : 6,979.75 (-0.04%)
PSKY : 13.74 (+1.55%)
SRDX : 42.98 (+0.35%)
LRCX : 177.33 (+1.24%)
VSAT : 35.15 (-2.06%)
$DOWI : 48,731.16 (+0.60%)
Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

Surmodics, Inc. (Nasdaq: SRDX) (“Surmodics” or the “Company”), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United...

SRDX : 42.98 (+0.35%)
Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

Analysis of the all-comers PROWL Registry demonstrated high procedural success and safety in a cohort reflecting the real-world complexity of patients with symptomatic limb ischemia, over 40% of whom had...

SRDX : 42.98 (+0.35%)
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

PROWL Registry evaluates the Pounce™ Thrombectomy Platform for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature. Updated safety and performance data from 160 patients...

SRDX : 42.98 (+0.35%)
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform

Analysis of 160 patients with acute, subacute, or chronic symptoms of thrombotic limb ischemia receiving thromboemboli removal treatment with the Pounce™ Thrombectomy Platform demonstrated high procedural...

SRDX : 42.98 (+0.35%)
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28

PROWL Registry evaluates the Pounce™ Thrombectomy Platform for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature. Results of a sex-specific analysis of 160 patients...

SRDX : 42.98 (+0.35%)
SurModics: Fiscal Q3 Earnings Snapshot

SurModics: Fiscal Q3 Earnings Snapshot

SRDX : 42.98 (+0.35%)

Business Summary

Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.'The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable...

See More

Key Turning Points

3rd Resistance Point 44.53
2nd Resistance Point 43.77
1st Resistance Point 43.37
Last Price 42.98
1st Support Level 42.22
2nd Support Level 41.46
3rd Support Level 41.06

See More

52-Week High 43.00
Last Price 42.98
Fibonacci 61.8% 36.46
Fibonacci 50% 34.44
Fibonacci 38.2% 32.42
52-Week Low 25.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar